Share information
Latest news
EQT AB publishes Annual and Sustainability Report for 2023
EQT Life Sciences portfolio company Amolyt Pharma to be acquired by AstraZeneca for up to USD 1.05 billion
EQT Private Equity to sell its 20% stake in Ottobock, the global leader in wearable human bionics
EQT AB hosts Capital Markets Day
Galderma, an EQT Private Equity portfolio company, announces its intention to conduct an Initial Public Offering